Neurosciences
ROCHESTER, Minn. — An international study led by Mayo Clinic researchers has identified interleukin-6 (IL-6) receptor blockers as a promising option for preventing relapses in[...]
Latest stories
Featured News
April 30, 2025
Transplant
April 30, 2025
Cardiovascular
April 29, 2025
Individualized Medicine
April 23, 2025
Individualized Medicine
April 22, 2025
Sign up to receive email notifications
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community